AZN 2026-08-19 AstraZeneca Vs. Bristol-Myers Squibb: Who's The Better Bargain For Investors?
ALLKA Research NYSE
Bristol Myers Squibb CO
BMY
2 articles
$134B Market cap · 2026-08-20
AZN 2026-08-19 ALLKA Research 
A non-consensus thesis: the forthcoming demise of Bristol Myers Squibb.
Bristol Myers Squibb’s bear case centers on patent-cliff revenue losses, debt, and failed drug investment after $28.3 billion of 2019–23…
